WALGREEN CO. Brandon Lee Minghui Li Jeremy Smith April 29, 2008.

Slides:



Advertisements
Similar presentations
INDIANA UNIVERSITY FALL 2002 WHO? WHAT? WHEN? WHERE? WHY?
Advertisements

Apple Inc. (AAPL) Covering Analyst: Cameron Schwartz
Analysts: Su Chen Gina Huang Xuhao Yang Jonathan Barki Date: November 10 th,
First Industrial Realty Trust Caitlin E. Bizzotto Zhenzhong (Linden) Lu Xiaoting Yang Zheng (Andrea) Zhang RCMP Presentation
VALUATION OF FIRMS IN MERGERS AND ACQUISITIONS OKAN BAYRAK.
Morgan Stanley December 7th, 2004 By Adam Freda.
MGMT 315: Financial Valuation Project Ashli Edwards, Xiang Li, and Katerina Goudouros.
Synergy Value Evaluation Background Equity Value VS.
WALGREEN CO. Matt Byford Brandon Honey Shivam Khanna Joe Vaccaro October 28, 2008.
PRESENTED MAY 5, 2009 Alan Lagunov Bobby Schuster Michal Wojcikowski.
CHAPTER 23 Consumer Finance Operations. Chapter Objectives n Identify the main sources and uses of finance company funds n Describe the risk exposure.
NYSE: WAG Junying Shen Xiaosi (Sarah) Song Chi (Tracy) Zhang Xiangyuan (Arthur) Zhong Nov 6, 2012.
A pharmacy giant in the making
FORECASTING PERFORMANCE Presented by: Teerachai Supojchalermkwan Krisna Soonsawad Chapter 11.
Evaluating Popular Investments Lesson 3 Corporate Fundamental Analysis.
National HealthCare Corporation December 2, 2014 Ricky Fang, Fan Fei, Jacob Stoiber.
Muge Tian Yanlei Xu Ben Hier Mohamed Ibrahim November 29, 2007.
Security Analysis. Learning Goals Analyzing shares based on Economic, Industry and Fundamental of the company Analyzing shares to determine WHAT shares.
EM-Trade | Agenda Interviews Poker Tournament Fantasy Stock Market
COMPANY PRESENTATION Walgreen Company An Overview.
Chapter 12 Part 2. INDUSTRY A group of companies producing similar products or services Example: Soda 
Williams Sonoma Annual Report Justin Kovacsik ACG
Netgear, Inc April/03/2012 Presentors: Ryo-Seob(Joseph) Kim Jionghan(JD) Dai Han(Henry) Yang Pattharaporn (Pauline) Lertphaiboonsiri Yen-Hua(Gina) Huang.
Green Mountain Coffee Roasters, Inc.
Our Mission... To be the most convenient provider of consumer goods & services... and Pharmacy, and Health & Wellness services...in America.
NYSE: WAG April 29 th, 2014 Leiyi (Sally) Huang Qun (Jett) Yu Siyang (Sylvia) Zhang.
First Industrial Realty Trust November 20, 2008 Brian Bird Ryan Foelske.
Limited Brands, Inc. Dixie Moseley ACG 2021 Section 002.
QB March 2011 Presentation by the South African Reserve Bank to the Portfolio Committee on Finance Quarterly Bulletin March April 2011.
Maria Alejandra Ramirez ACG Annual Report.
Walgreens David Mizell Date Presented: 12/09/2004.
Annual Report Nissan Motor Co., Ltd. Scott Nelson ACG2021 sec 080.
MCD (NYSE) MENGYU SUN JUNYING SHEN CHI ZHANG October 30,2012
VALUATION MEASURING AND MANAGING THE VALUE OF COMPANIES
Investor Presentation November Forward Looking Statements This presentation may contain forward-looking statements which are subject to a number.
Stock Trading 102 Seminar Arlen Novelli, Sesame Chen, Stefan Filipovic and Abby Holtan.
WALGREENS Andy Guar, Akrati Johari, Mike Lavin, Yanyan Xu, Yili Xu Presented on 10/22/2009 Akrati Johari (akratij gmail.c om)
Analyzing Financial Statements
Walgreens Acquires Familymeds Pharmacies Matt Thompson Stu Beurskens.
Presented on November 12th, 2015
Company Overview  Small-Mart originated in 1969 under the leadership of Sam Smallton. Small-Mart is the largest superstore chain in the United States.
Yujiang Chen (Walter) Zeyu Chi Yin-Jen Kao Ming Li Yuqing Zhang
American Eagle Outfitters (AEO) Presented December 2, 2008
American Eagle Outfitters, Inc.
Walgreen Co. (WAG) Presented April 19, Investment Managers Jessica Boghosian Shengdong Zhu
Chapter 9 The Cost of Capital. Copyright ©2014 Pearson Education, Inc. All rights reserved.9-1 Learning Objectives 1.Understand the concepts underlying.
Charlie Penicook and Zuowei Xu November 19, 2013.
American Eagle outfitters Presented by : Linden Lu Yanlei Xu Yanlei Xu Gleb Zarkh Gleb Zarkh Mohamed Ibrahim Mohamed Ibrahim
 Fundamental Analysis By Martin Brenner. What is Fundamental Analysis?  A method of evaluating a security that entails attempting to measure its intrinsic.
Aditi Das Pien-Cheng WeiSashikanth Yenika Yanan Tan Yin Jen Kao (NYSE: COF) Investment Managers:
PetSmart Corp. Real Client Managed Portfolio PetSmart (PETM) November 14, 2013 Alex Johansson, Charlie Penicook & Zi Jian Gu.
Kaitlyn Emerick Keiarra Ragland Victoria Saber. Agenda:  Company Introduction  Overview Analysis  Analysis of Firm Riskiness  Financial Statement.
Walgreens Boots Alliance NASDAQ: WBA Presented by Zhi Cheng (Nicole) Low Yanan (Phoebe) Tan Zulay Sosa Bazante Rahul Gohil Shruti Shah Presented on March.
1 Research term paper Five major sections: Company background / introduction Competitive strengths Financial analysis (focus section) Stock valuation analysis.
Seagate Technology PLC Kyle Gesuelli. Which securities fit with the portfolio’s strategy and make sense in the current market? STX comprises largest loss.
Jiaze Li Ningzhou Fang October 18, 2016.
Industry Analysis Food and staples retailing, 2nd largest segment of consumer staples industry Pros: defensive, stable growth, dependable revenue, low.
Tyler Hand , Enrique Cruz, Skye Galley
Jack Henry & Associates, Inc
Analysts: Minhao Gu, Tian Luo, Tim Widick
Carriage Services, Inc. Manik Malhotra Quintus Yang
Investments in Other Corporations
Intercorporate Investments and Consolidations
Flexsteel Industries, Inc.
Verizon Communications Inc.
Paul Verdier, Xiang Wu, Huiwu Wang, Zhihao Wang
VALUATION OF FIRMS IN MERGERS AND ACQUISITIONS
Financial Industry Group 4/20/2011
X100 Introduction to Business
Tyler, Dave, Brandon, Jack
Presentation transcript:

WALGREEN CO. Brandon Lee Minghui Li Jeremy Smith April 29, 2008

Agenda Company Overview Industry and Economic Analysis Valuation Recommendation Q & A

Company Overview Walgreen company operate retail drug store chains that are engaged in the retail sale of prescription drugs, non-prescription drugs, and general merchandise. In 2008, it opened 536 net new stores for a total of 5997 Walgreens in 48 states and in Puerto Rico. It is the fastest growing retailers in the US, and is the leader in the chain drugstores. Ranked 44 th on the Fortune 500 list of the largest US-based companies. On the list of Fortune’s magazine’s Most Admired Companies in America for the last 14 consecutive years.

Business Drugstores Prescription drugs Nonprescription Drugs General merchandise Take care Health clinics Home infusion Therapy provider Specialty pharmacy

Product class Prescription65%64% 63% Non-prescription10%11% 12% General Merchandise25% Prescription sales continue to become a larger portion of the company’s business.  Aging population  Introduction of lower priced generics  Continued development of innovative drugs

Growth Strategy Opening new stores Walgreen expected to operate more than 7000 stores in 2010

Growth Strategy Acquisitions provide a unique opportunity and strategic fit for Walgreen business. Fiscal 2007:  100% of the outstanding shares of Option Care, Inc. and affiliated companies  Positioned Walgreen as the nation’s largest home infusion therapy provider and the fourth largest specialty pharmacy provider.  100% ownership of Take Care Health System, Inc and LLC, a convenient care clinic operator  Selected assets of Familymeds Group, Inc.  Remaining minority interest of SeniorMed LLC.

Growth Strategy Investment in technology and customer service initiatives Revenue (from 1998 to 2007) $MilFiscal year-end: 8

Fundamental Multiples P/E ratio kept declining stably with the increases in sales. Underlying story remains unchanged. Investors reconsidered the intrinsic value and the risk in the business of Walgreen.

Walgreen Outlook Advantages : Good reputation: Walgreen is a quality name. Convenience of locations: Walgreen stores usually position on high traffic corners, and around large residential locations. High market share translating into scale benefits. Pricing advantage results from scale and high volume. Aging population Risk factors:  Peaking generic drug cycle: It is anticipated that there are no major generic drug introductions in  Store saturation  Competition from CVS/Caremark

Major Financial Activities Stock repurchase program: 2007 repurchased program: up to $1billion of the company’s common stock, expiration date on January 10, repurchased program: completely executed in three years During fiscal 2007, the company purchased $344.9million of shares related to the 2007 repurchased program, million of shares related to the 2004 repurchased program Short-term borrowings: In the fiscal 2007, the company issued commercial paper to support working capital needs. Credit ratings as of August 31, 2008: Rating AgencyLong-term debt ratingsCommercial paper rating Moody'sAa3P-1 S&PA+A-1

Industry Overview Retail (Drugs) Industry  Highly competitive Saturated market Companies looking to enhance retail channels through online and mail order sales  Rx sales $ Bln in 07’ vs. $ Bln in 06’ Main Competitors:  CVS Caremark, Medco, Rite Aid Industry Business Segments:  “Prescription drugs, proprietary drugs, and non- prescription medicines, and which may also carry a number of related lines, such as cosmetics, toiletries, tobacco, and novelty merchandise”

Industry Performance Walgreens, Co. (2007, Oct 26) Retrieved April 26, 2008, from SEC.gov

1 Yr. Stock Performance Accessed: April 25, 2008.

Macroeconomic Overview Credit Crunch  Since late 2007, economic slowdown in response to housing woes  Tougher for companies to access cheap debt Slowed Growth in GDP Decline in Consumer Confidence  Provides insight to market direction a 5 year low (March 2003, 61.4)

 Decline in Consumer Confidence  Provides insight to market direction a 5 year low (March 2003, 61.4) Macroeconomic Overview

Macroeconomic Factors Rapid growth in price of Oil High prices have a negative impact on the economy  Costs to the businesses increase Ui.size=620x300&chartUi.minutes=; Accessed: April 1, 2008.

RCMP Position: Purchased 1000 shares of WAG on October 6 th, 1999 for $25.00/share. On September 20 th, 2006, sold 500 $49.94/share for a realized gain of $12,470. Currently own 500 shares of WAG, trading at $35.48 as of April 28, 2008 for an unrealized gain of $5,240 or 41.92%.

RCMP Portfolio

Correlation:

Operating Leases: Operating leases are not reflected as assets or liabilities on the balance sheet.  Does not reflect the cumulative economic liability for all future lease payments Results:  Reduce the likelihood of a debt covenant violation  Increase ability to obtain future additional loans  Improve financial ratios like debt-to-equity ratio

Lease Obligations: Walgreens owns 19.1% of its stores, leasing the remaining 80.9%. Present value of lease obligations is $ billion  Can be viewed as debt Should consider the risk of this these lease obligations

DCF Assumptions: WACC Calculation:  Weight of Equity: 100%  Weight of Debt: 0%  R f = 4.05%  Beta =.75 (taken from March 2008 Value Line)  k e = 8.55%  Long Term Growth Rate = 4.00%  WACC = 8.55%  DCF Value = $35.19  DCF Range = $31.67 – $38.71

Comparables: Source: Accessed: April 28, 2008http://finance.yahoo.com/q/co?s=WAG

Recommendation: HOLD existing 500 shares of WAG  Consistently beating Wall Street expectations  Continues to open new stores at 8% rate per year